Properties of human anti-group B streptococcal type III capsular IgG antibody

Clinical Immunology and Immunopathology

Volumn 86, Issue 2, 1998, Pages 161-169

  Feldman, Robert G ^a,b,c   Breukels, Mijke A ^b   David, Silke ^b   Rijkers, Ger T ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Antibody affinity; Opsonophagocytosis; Streptococcus agalactiae

Indexed keywords

CARBOHYDRATE; COMPLEMENT; IMMUNOGLOBULIN G ANTIBODY; OPSONIN; STREPTOCOCCUS ANTIGEN; STREPTOCOCCUS VACCINE;

ANTIBODY AFFINITY; ARTICLE; BACTERIAL MEMBRANE; BINDING KINETICS; CONTROLLED STUDY; DISSOCIATION CONSTANT; HUMAN; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION;

EID: 0032007025     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1997.4461     Document Type: Article

References (30)

1. Baker C. J., Edwards M. S. Group B streptococcal infections. Infectious Diseases of the Fetus and Newborn Infants. 1990;W. B. Saunders, Philadelphia. p. 742-811.
2. MMWR-Recommendations Rep. 45:1996;1-24.
3. Baker C. J., Rench M. A., Edwards M. S., Carpenter R. J., Hays B. M., Kasper D. L. Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus. N. Engl. J. Med. 319:1988;1180-1185.
4. Wessels M. R., Paoletti L. C., Kasper D. L., DiFabio J. L., Michon F., Holme K., Jennings H. J. Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus. J. Clin. Invest. 86:1990;1428-1433.
5. Robbins J. B., Schneerson R., Vann W. F., Bryla D. A., Fattom A. Prevention of systemic infections caused by group B streptococcus and Staphylococcus aureus by multivalent polysaccharide-protein conjugate vaccines. Ann. N. Y. Acad. Sci. 754:1995;68-82.
6. Kasper D. L., Paoletti L. C., Wessels M. R., Guttormsen H. K., Carey V. J., Jennings H. J., Baker C. J. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. J. Clin. Invest. 98:1997;2308-2314.
7. Baker C. J., Kasper D. L. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N. Engl. J. Med. 294:1976;753-756.
8. Feldman R. G., Ferrante A. Prevalence of anti-group B streptococcal type III capsular IgG antibodies in the United Kingdom and an analysis of their specific IgG subclasses. J. Infect. Dis. 162:1990;883-887.
9. Anthony B. F., Concepcion N. F., Wass C. A., Heiner D. C. Immunoglobulin G and M composition of naturally occuring antibody to type III group B streptococci. Infect. Immun. 46:1984;98-104.
10. Kasper D. L., Goroff D. K., Baker C. J. Immunochemical characterization of native polysaccharides from group B streptococcus: the relationship of the type III and group B determinants. J. Immunol. 121:1978;1096-1105.
11. Feldman R. G., Hamel M. E., Breukels M. A., Concepcion N. F., Anthony B. F. Solid-phase antigen density and avidity of antibodies detected in anti-group B streptococcal type III IgG enzyme immunoassays. J. Immunol. Methods. 170:1994;37-45.
12. Eisenstein T. K., De Cueninck B. J., Resavy D., Shockman G. D., Carey R. B., Swenson R. M. Quantitative determination in human sera of vaccine-induced antibody to type specific polysaccharides of group B streptococci using an enzyme-linked immunosorbent assay. J. Infect. Dis. 147:1983;847-856.
13. Harlow E., Lane D. P. Antibodies: A Laboratory Manual. 1988;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
14. Gray B. M. ELISA methodology for polysaccharide antigens: protein coupling of polysaccharides for adsorption to plastic tubes. J. Immunol. Methods. 28:1979;187-192.
15. MacDonald R. A., Hosking C. S., Jones C. L. The measurement of relative antibody affinity by ELISA using thiocyanate elution. J. Immunol. Methods. 106:1988;191-194.
16. Lancefield R. C., McCarthy M., Everly W. N. Multiple mouse-protective antibodies directed against group B streptococci. J. Exp. Med. 142:1975;165-179.
17. Mayer M. M. Complement and complement fixation. Kabat E. A., Mayer M. M. Experimental Immunochemistry. 1967;133-240 Thomas, Springfield.
18. Bjerknes R., Bassøe C. F., Sjursen H., Laerum O. D., Solberg C. O. Flow cytometry for the study of phagocytic functions. Rev. Infect. Dis. 11:1989;16-33.
19. Sanders L. A. M., Feldman R. G., Voorhorst-Ogink M. M., de Haas M., Rijkers G. T., Capel P. J. A., Zegers B. J. M., van de Winkel J. G. J. Human-immunoglobulin G (IgG) Fc-receptor-IIA (CD32) polymorphism and IgG2-mediated bacterial phagocytosis by neutrophils. Infect. Immun. 63:1995;73-81.
20. Sahlin S., Hed J., Rundquist I. Differentiation between attached and injested immune complexes by a fluorescence quenching cytofluorimetric assay. J. Immunol. Methods. 60:1983;115-124.
21. George A. J. T., French R. R., Glennie M. J. Measurement of kinetic binding constants of a panel of anti-saporin antibodies using a resonant mirror biosensor. J. Immunol. Methods. 183:1995;51-63.
22. Kim K. S., Wass C. A., Hong J. K., Concepcion N. F., Anthony B. F. Demonstration of opsonic and protective activity of human cord sera against type III group B streptococcus that are independent of type-specific antibody. Pediatr. Res. 24:1988;628-632.
23. Ahlstedt S., Holmgren J., Hanson L. Å, ;. Protective capacity of antibodies against E. coli O antigen with special reference to the avidity. Int. Arch. Allergy Appl. Immunol. 46:1974;470-480.
24. Fauci A. S., Frank M. M., Johnson J. S. The relationship between antibody affinity and the efficiency of complement fixation. J. Immunol. 105:1970;215-220.
25. Steward M. W., Lew A. M. The importance of antibody affinity in the performance of immunoassays for antibody. J. Immunol. Methods. 78:1985;173-190.
26. Käyhty H., Karanko V., Peltola H., Mäkelä P. H. Serum antibodies after vaccination with Haemophilus influenzae type b capsular polysaccharide and responses to reimmunization: No evidence of immunological tolerance or memory. Pediatrics. 74:1984;857-865.
27. Knisley K. A., Rodkey L. S. Affinity immunoblotting. J. Immunol. Methods. 95:1986;79-87.
28. Riesen W. F., Skvaril F., Braun D. G. Natural infection of man with group A streptococci: levels, restriction in class, subclass and type, and clonal appearance of poly-saccharide group-specific antibodies. Scand. J. Immunol. 5:1976;383-390.
29. Morris R. J. Antigen-antibody interactions: how affinity and kinetics affect assay design and selection procedures. Ritter M. A., Ladyman H. M. Monoclonal antibodies: Production, Engineering and Clinical application. 1995;34-59 Cambridge Univ. Press, Cambridge.
30. Beuvery E. C., van Rossum F., Nagel J. Comparison of the induction of immunoglobulin M and G antibodies in mice with purified pneumococcal type 3 and meningococcal group C polysaccharidies and their protein conjugates. Infect. Immun. 37:1982;15-22.